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Palliative or compassionate withdrawal of mechanical ventilator support at the 
end of life aims to optimize comfort, alleviate suffering, and allow a natural death 
in patients for whom life supports are not achieving desired goals. Palliative with-
drawal is a medical procedure and must be treated as such. Appropriate planning 
and preparations are required to optimize patient comfort, which is the goal of the 
procedure. Many institutions have a “one size fits all” approach to this process, but 
individual patient factors require consideration to meet the patient’s needs. Some 
of these factors include patient pathophysiology (airway edema, airway trauma, 
hemoptysis, secretions), current treatment modalities (ventilator settings, medica-
tions including sedatives, vasopressors, inotropes, inhaled agents, neuromuscular 
blockade agents), and patient and family values and preferences. This chapter will 
discuss the implications of each of these factors and propose methods for successful 
transitions to comfort-focused care. Case vignettes will demonstrate the thought 
processes involved and model optimal management. Common ethical considerations 
and questions regarding palliative withdrawal of life support will also be discussed.
Keywords: Palliative, terminal, Withdrawal, comfort care, end of life
1. Introduction
Palliative or compassionate withdrawal of mechanical ventilator support at the 
end of life aims to optimize comfort, alleviate suffering, and allow a natural death 
in patients for whom life supports are not achieving desired goals. Medical ethics 
discussions have shifted significantly over the decades since critical care was first 
developed. It is now generally, though not universally, accepted that withdrawal 
of life support is equivalent to withholding of life support. Some now argue that 
withdrawal may be ethically superior to withholding life support, as withholding 
assumes the life support will not achieve the patient’s goal, while withdrawal occurs 
only after this assumption has been proven true [1].
2. Decision-making process
A patient with capacity must be given the opportunity to participate in 
decision-making. This can be challenging when medical interventions limit audible 
speech, as with an oroendotracheal or nasoendotracheal tube. While sometimes 
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time-consuming, solutions such as computers or tablets with keyboards, phones with 
texting capabilities, sign language, letter boards, or simply pen and paper, can allow 
a patient to ask questions and express their own values, goals, and preferences. Some 
patients with a tracheostomy tube in place can generate audible fricative speech, even 
when the cuff must remain inflated for respiratory support. Some patients with either 
tube can mouth words clearly enough to be understood, though this can be difficult for 
both patient and medical team. The powers of the Power of Attorney may be limited 
by the patient, or by local laws, but generally allow the surrogate to make medi-
cal decisions on the patient’s behalf when the patient is unable or chooses to defer. 
Capacity for medical decision-making is a complex construct and can vary over time, 
and with the decision to be made. Some patients are unable to process any significant 
medical information. Some are able to process and express clear and consistent 
preferences about simpler matters but not complex ones. As with language interpreta-
tion, these interpretations must be made by a member of the medical team and not 
exclusively by family or friends of the patient, and must be confirmed with the patient 
in other ways, such as nodding or shaking their head to confirm or refute accuracy.
A patient with capacity can also choose to defer to their legal surrogate, and in 
many jurisdictions can select and assign Power of Attorney for Health Care to one 
or more people to speak for them.
Still others are able to understand, manipulate, and ask questions about the 
medical information presented to them, and to express clear, consistent decisions 
on their own behalf.
3. When to discuss withdrawal of life supports
Ideally, physicians discuss with each patient their prior experiences, values, 
preferences, goals, and minimal acceptable outcomes prior to onset of critical 
illness, and prior to initiation of life supports. This is often not possible, sometimes 
due to the acute nature of some critical illnesses, and sometimes due to patient 
factors such as unwillingness to discuss these issues. Unfortunately, this is also 
sometimes due to physicians’ and medical teams’ discomfort with, inadequate time 
for, or failure to recognize the necessity of such discussions.
Regardless of whether routine or baseline discussions of experiences, values, 
preferences, and goals have occurred, the onset of critical illness is an important 
prompt to discuss or rediscuss these thoughts. Ideally, at the beginning of a patient’s 
critical illness, their physician discusses with the patient or surrogate, or with both, 
the presumed diagnosis, the treatment options, and the likely outcomes of each and 
how soon the outcomes are anticipated. The patient or surrogate ideally understands 
and integrates this information and selects the treatment that gives them the best 
chance of recovery within the parameters of acceptable risk and acceptable burdens 
or suffering defined by that individual patient. After learning the patient’s risk 
and burden tolerance, the physician confirms and documents the treatment plan, 
including any limits set by agreement with the patient or surrogate. The physi-
cian should then schedule a date to discuss progress, or lack of improvement, and 
further options with the patient or surrogate, unless new findings or changes require 
significant discussions sooner. This constitutes a time-limited trial, which is a useful 
framework for acknowledging the uncertainty of outcomes of critical illness [2].
If the patient is not improving to the extent they themselves would require to 
make continuing current life supports acceptable, or if the patient, or surrogate 
acting in the patient’s best interest, finds the current life supports too burdensome 
despite good efforts at symptom management by the medical team, it is important 
to discuss the option of palliative withdrawal of life supports.
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When multiple life supports are present, and the patient or surrogate and 
team are considering withdrawing one form of life support, it is necessary to 
consider whether or not the other forms of life support present are contributing 
to achievable medical goals. If any form of life support is not helping the patient 
progress toward achievable goals, potential withdrawal should be considered and 
discussed.
4. How to withdraw mechanical ventilation
Palliative withdrawal is a medical procedure and must be treated as such. 
Appropriate planning and preparations are required to optimize patient comfort, 
which is the goal of the procedure. Many previously published works, and many 
institutions have a “one size fits all” approach to this process, but individual patient 
factors require consideration to meet the patient’s needs. Unfortunately, for under-
standable reasons, at this time there are exceedingly few studies of how to perform 
any part of this procedure. Therefore, many aspects require logical consideration 
and expert opinion to guide practice, as well as consideration of the individual 
patient’s condition, needs, preferences, and goals.
Evidence suggests family satisfaction is increased when a step-wise approach to 
withdrawal of life support is used [3].
4.1 Ventilator weaning vs. immediate discontinuation
Older literature regarding palliative withdrawal of life supports generally 
describes either universal weaning or universal immediate discontinuation. 
More recent literature and guidelines take a more patient-centered, case-specific 
approach and recommend consideration of the patient’s current ventilator support 
requirements and level of symptoms [4]. For patients on moderate or high ventila-
tor support, it is recommended to wean ventilator support - specifically positive end 
inspiratory pressure (PEEP), potentially pressure support, and fraction of inspired 
oxygen (FiO2) - in a step-wise approach, titrating opioids and benzodiazepines 
especially to control dyspnea and anxiety respectively.
For example, for a patient who is on assist control volume control with a set rate 
of 14, tidal volume 6 mL/kg ideal body weight, PEEP of 14 cmH2O, and FiO2 60%, 
it would be advisable to achieve comfort with medications before initiating wean-
ing, then reduce PEEP and FIO2 to 10–12 and 40% respectively, titrate medication 
boluses to achieve and maintain comfort, and continue to wean ventilator support 
every 15-30 minutes as tolerated.
4.1.1 Mode
Modern ventilators allow for a wide variety of mandatory, intermittent manda-
tory, assisted breath, and entirely spontaneous modes. Each mode has potential 
benefits and potential burdens to the patient.
When transitioning to comfort measures, patient condition and clinician com-
fort with managing the various modes will determine optimal mode for weaning 
or continued support. A patient who is awake, alert, and requires little ventilator 
support may be most comfortable right away with low levels of pressure support 
and PEEP. A patient with poor lung compliance or with neurologic or myopathic 
limitations to breathing may require a more sensitive trigger or a more controlled 
mode that ensures volume delivery, and for some, having a minimum breath 




In modes with a set minimum rate, reducing a rapid set rate may unmask 
intrinsic tachypnea, which may be physiologic, or may be due to pain or anxiety. In 
synchronized intermittent mandatory ventilation settings, reducing the set rate may 
increase the frequency of spontaneous breaths; depending on the level of support 
provided with these spontaneous breaths, patients may feel more dyspnea if under-
supported, or less dyspnea if their respiratory efforts are sufficiently supported.
4.1.3 Peep
Reducing PEEP can allow pulmonary edema, alveolar secretions, or pulmonary 
hemorrhage to become more prominent. Some patients may experience increased 
cough and may have difficulty expectorating the secretions. A stepwise approach, 
reducing PEEP by 2–4 cmH2O per step, may allow for titration of symptom control 
medications. Most ventilators have backup apnea settings that cannot be discontin-
ued. For patients who are maintained on ventilator support throughout the comfort 
care process, it is important to remind families and team members that the ventila-
tor will continue to deliver breaths even after the patient has died.
4.1.4 Oxygen
Some patients are asymptomatic or relatively asymptomatic with hypoxemia, 
while others note symptoms with even relatively small reductions in oxygenation. 
Again a stepwise approach, reducing by approximately 20% per step, allows for 
symptom management with medication titration. Supplemental oxygen through the 
ventilator can be weaned to as low as 21%, especially if the plan is for discontinua-
tion of ventilator support without supplemental oxygen.
4.1.5 Tidal volume
Since the first ARDSnet trial publication [5], when tidal volumes are set on the 
ventilator, they are commonly set to a low tidal volume, lung protective strategy 
of 8 mL or less per kilogram of ideal body weight. Some patients find this strategy 
uncomfortable, as it forces small, limited volume breaths. If ventilator support is to 
be continued, especially if awaiting arrival of family members, or another signifi-
cant event, continuing the current set volume is typical, but liberalizing the set 
volume somewhat may improve comfort.
4.1.6 Drive pressure, inspiratory pressure, or pressure support
These terms all refer to pressure added by the ventilator for the inspiratory phase 
of each breath to inflate the lungs and generate a tidal volume. The size of the tidal 
volume depends on the pressure administered and on the patient’s lung and airway 
compliance. For patients with acute lung injury or acute respiratory distress syn-
drome, the pressure is generally set to target lung protective low tidal volumes. For 
patients without lung injury, the pressure requirement may be fairly low, or may be 
set to allow more liberal breath sizes for comfort.
4.2 Extubating vs. maintaining oro- or nasoendotracheal tube
Many institutions, and some older articles written about the process of palliative 
withdrawal of life supports, have a near-universal practice of removing the patient’s 
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oral (or nasal) endotracheal tube. It is generally assumed that patients and families 
prefer extubation and will be more comfortable after removal of the tube. However, 
there are some important considerations that may limit or worsen patient comfort 
after removal of these tubes. Airway compromise caused by edema, trauma, 
masses, or other lesions may make removal of the oro- or nasoendotracheal tube 
risky for causing or allowing burdensome symptoms to occur. Similarly, significant 
hemoptysis or secretions, whether purulent or edematous, may require excessive 
effort by the patient to clear, and may limit comfort after extubation.
Decades ago, some institutions also routinely removed tracheostomy tubes at 
end of life. Unless there are specific patient-centered reasons to do so, this is no 
longer recommended.
4.3 Sedatives, analgesics, anxiolytics
4.3.1 Basal rate titration vs. bolus dose administration
As with enteric opioid medication administration, as needed bolus dose 
administration and titration should be the mainstay of symptom management. 
Anecdotally, ICU physicians and nurses often treat opioid and benzodiazepine 
infusions as though they have the pharmacokinetic and pharmacodynamic proper-
ties of vasopressors in terms of time to peak effect and time to steady state. This 
is not consistent with the actual activity of these medications, and can cause 
both ineffective symptom management initially, and excessive dosing later in the 
patient’s course.
Pharmacologic principles must be remembered and utilized in the manage-
ment of infusions of opioids and benzodiazepines. When a patient has significant 
symptoms, bolus doses can and should be administered as often as the time to 
peak effect for the drug in question. If the bolus dose is effective in controlling 
symptoms, the dose can be repeated after time to peak effect when it is needed 
again. If the dose is only moderately helpful for symptom control, the dose can be 
increased by 50% at the next administration to improve efficacy. And if the dose is 
minimally or ineffective, the dose can be doubled at the next dosing interval, or an 
alternative medication can be considered.
4.3.2 Propofol
Propofol is an anesthetic and sedative without analgesic properties. Some 
institutions restrict use without a secured airway. However, it can have benefits, 
including control of seizures, and may occasionally be a helpful adjunct to symp-
tom control for those with severe anxiety, for example, where the patient prefers 
deep sedation over the possibility of experiencing their severe symptoms at end 
of life.
4.4 Inhaled vasodilator agents
There are no significant studies to inform best practices on withdrawal of 
inhaled pulmonary vasodilators. Generally it is probably reasonable to discon-
tinue the agent at the start of transition to comfort measures, before weaning any 
ventilator settings. Based on half life, symptoms may become significant or severe 
approximately 15 minutes after discontinuing nitric oxide, or 25 minutes after 
discontinuing inhaled epoprostenol. Opioid administration as needed for dyspnea 
or chest pain, and benzodiazepine administration as needed for anxiety after 
discontinuation are the mainstays of management.
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4.5 Neuromuscular blockade agents
Medication must be stopped and effect must be absent prior to withdrawal 
of life support to ensure ability to demonstrate any discomfort they are experi-
encing, and to avoid active euthanasia by this mechanism. Even if practicing in 
a jurisdiction where active euthanasia is legal, withdrawing life support in the 
presence of neuromuscular blockade is not acceptable because of the temporary 
and avoidable inability to actively monitor for symptoms and address them 
during the process.
Ethically, this differs from palliative withdrawal of life support in a neurologi-
cally devastated person who is intrinsically unable to demonstrate discomfort 
during end of life care because their inability to demonstrate discomfort is 
permanent and irreversible. In this case, for a patient whose surrogate feels the 
patient would not wish to continue life sustaining treatments, best practice is to 
aggressively treat for potential symptoms, using changes in vital signs as markers 
for possible distress and treating accordingly.
Ideally, neuromuscular blockade infusion can be stopped at the initiation of the 
transition to comfort measures and the effect allowed to wear off gradually as the 
drug is metabolized. Cessation of neuromuscular blockade allows patients to physi-
cally express whether symptoms such as pain, anxiety, dyspnea, or other forms of 
distress are present.
However, in some instances, patients may have such severe hypoxemia that 
oxygenation may start to falter before the drug effect is entirely resolved, some-
times to the point that the patient could die before physical symptoms can be fully 
assessed. In such situations, reversal of neuromuscular blockade may be consid-
ered, with neostigmine and glycopyrrolate for any agent, or with sugammadex for 
rocuronium or vecuronium only.
4.6 Dialysis
When to discontinue dialysis is highly dependent on the patient’s situation. For 
patients with volume overload who are on continuous dialysis, continuing volume 
removal at least until the time of ventilator withdrawal or extubation may improve 
comfort by reducing pulmonary edema and whole body anasarca.
For patients with end-stage renal disease, some patients tolerate dialysis well and 
feel better with continuing it. In the United States, patients who enroll in hospice 
for a terminal diagnosis not related to their end-stage renal disease may be able to 
continue outpatient dialysis for a time; this is generally situation-dependent.
4.7 Vasopressors and inotropes
Optimal timing of withdrawal of vasopressors and inotropes is dependent on the 
situation. For less responsive patients, some physicians recommend discontinuing these 
early in the course of withdrawal of life supports, to induce a hypotensive or hypoper-
fusion-related encephalopathy, with the hope of reducing experience of symptoms 
through this mechanism. Other physicians elect to continue pressors until symptoms 
are noted to be well controlled after completion of palliative ventilator weaning or 
withdrawal to ensure medications can be circulated through the body to maximize their 
effect. Still other physicians discontinue vasopressors and inotropes concurrent with 
early palliative ventilator withdrawal. To date, there are no studies examining optimal 
timing; clinical judgment regarding which strategy will most likely meet the individual 
patient’s values, goals, and preferences in light of their condition is needed.
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4.8 Pacemakers and implanted cardiac defibrillators
Implanted Cardiac Defibrillators (ICDs) should be deactivated as soon as transi-
tion to comfort measures is started, if not already deactivated with DNR order. 
Implanted pacemakers are typically not deactivated unless the pacemaker function 
is felt to be significantly prolonging the dying process. Temporary pacemakers are 
typically deactivated at some point during the withdrawal process; timing can be 
considered similar to vasopressors.
4.9 Lines, drains, and tubes
At the time of transition to comfort care, the medical team should discuss all 
lines, drains, and tubes in place and decide whether to maintain or remove each. 
Urinary catheters may be maintained or removed depending on patient preference 
and perceived comfort. Temporary central venous catheters and tunneled central 
venous catheters can generally be maintained unless causing discomfort; tempo-
rary catheters may be considered for removal if the patient will be discharged to a 
setting where use of the catheter may not be feasible.
Nasogastric and orogastric tubes can generally be removed unless continued 
gastric decompression is necessary or unless there are medications that absolutely 
must be continued for comfort after extubation. Orogastric tubes should almost 
always be discontinued if extubation is planned due to significant risk of gagging 
and oropharyngeal discomfort. Surgical drains and wound vacuum systems should 
be discussed with the surgical or wound care team.
Pulmonary arterial catheters and arterial lines generally do not improve comfort 
and should be removed at initiation of transition to comfort measures.
Chest tube management depends on the indication for placement. If a chest tube 
was initially placed for pneumothorax and maintained in place only because of 
continued positive pressure ventilation, clamping and removal can be considered, 
especially if ventilator support will be discontinued. Chest tubes placed for signifi-
cant, symptomatic pleural effusions likely should be continued to allow continued 
pleural drainage, unless pleurodesis has occurred. Those placed for pneumothorax 
that has not resolved likely should also be maintained and kept to suction to avoid 
symptomatic expansion of the pneumothorax. In all cases, the patient’s condition 
should be the driving factor in decision-making.
4.10 Artificial hydration and nutrition
The limited benefits and significant risks, harms, and symptoms induced by artifi-
cial hydration and nutrition should be discussed with the patient or surrogate prior to 
the palliative withdrawal process. Ideally these should be discontinued hours before 
initiation of the withdrawal process to avoid full stomachs or fluid overload. Patients 
who are able to express desire to eat or drink after extubation should be allowed to do 
so with caution and support, with a focus on comfort and quality of life.
5. Other consideration
5.1 Brain death
Jurisdictions may vary in their laws regarding management of patients diag-
nosed as brain dead. In some, the local organ procurement organization must be 
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notified and allowed to assess the patient for donation before withdrawal of life 
supports can be considered.
5.2 Organ and tissue donation
Depending on local or national laws regarding organ and tissue donation, the 
local organ procurement organization may be required to be notified prior to initia-
tion of the withdrawal process. It may also be required to allow the agency to assess 
the patient and discuss potential for donation with the patient or surrogate.
Ethically, clinicians involved in the patient’s care should not be involved in dis-
cussing organ or tissue donation. Perceived or real pressures to procure organs for 
other patients can adversely affect both decision-making processes of the patient or 
family and of the medical team. This can also erode the patient’s trust in the medi-
cal team to prioritize their needs and care. Discussions regarding organ and tissue 
donation should occur between the patient or family and procurement specialists 
not involved in the patient’s care.
6. Process of palliative ventilator withdrawal
6.1 Time out
Prior to the initiation of palliative withdrawal of life supports, the care team 
should convene to discuss the patient’s condition and formulate a plan consistent 
with the patient’s and family’s goals, values, and wishes, and making every effort 
to minimize or at least control symptoms. This process should be a formal, focused 
discussion and should occur before initiation in every case. The discussion should 
include the physician, bedside nurse, and respiratory therapist (RT) at least, ideally 
should include the chaplain, and the clinical pharmacist when needed.
Topics for discussion during the time out must include plans regarding timing 
of and method for withdrawing each form of life support, symptoms anticipated 
due to withdrawal of each life support, and plans for managing these symptoms. 
The team should also clarify which team member is to be the first point of contact if 
initial symptom management strategies are insufficient, or if other issues arise.
Where required, the local organ procurement organization must be notified of 
the plan for palliative withdrawal of life supports and anticipated or possible patient 
death prior to initiation of the process.
The bedside nurse in particular must be given support and time to focus exclu-
sively or nearly exclusively on the patient undergoing transition to comfort mea-
sures, to ensure a smooth transition with excellent symptom management.
Prior to initiation of any steps in the process of withdrawal, the appropriate Do 
Not Resuscitate order must be signed by the appropriate medical team member. 
Remaining full code while undergoing palliative withdrawal of life supports is 
completely counter to the goals of the process; it is absolutely predictable that at some 
point after withdrawal, cardiopulmonary arrest will occur and require either cessa-
tion of efforts based on futility, or require re-initiation of some forms of life support. 
At best, life supports required at this point might be the same as those in use prior to 
withdrawal, but more likely would include additional supports to sustain a condition 
that would at best be equal to the patient’s condition at the initiation of withdrawal. If 
the patient or surrogate desires resuscitative efforts at time of death, current manage-
ment should be continued. This can include agreed-upon plans to limit escalation 
(e.g., not adding additional pressors, dialysis, or other new therapies), or to plan to 
discuss progress, or lack thereof, at a specified date and time, typically a few days.
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The patient, surrogate, and family should be asked about what cultural or spiri-
tual practices related to death and dying are meaningful to them, and efforts should 
be made to support these needs and wishes. These can include Last Rites or specific 
prayers to be said prior to death, creating memorial items before or after death, and 
rituals regarding cleaning and care of the patient’s body after death. Some memorial 
items such as handprints, hand casts, recordings, and ECG tracings, can be made 
fairly easily and inexpensively. Some family members may wish to preserve locks of 
hair. It is essential to ask open ended questions and not project what the patient or 
family ‘should’ or ‘should not’ want at this point.
Once the plan is created and agreed upon, it should be reviewed with the patient 
as able, and with the family, to their desired level of detail. Anecdotally, many 
families and most patients are satisfied hearing that the plan for transition and 
withdrawal has been discussed and agreed upon by everyone participating, and has 
been designed to maximize the patient’s comfort.
Once transition has started, the bedside nurse should update the designated point 
of contact for the medical team to discuss any inadequately controlled symptoms or 
changes in clinical status.
After the patient’s death, family should be allowed and encouraged, but never 
forced, to assist in caring for the patient’s body after death. Specific cultural or 
religious practices regarding care and monitoring of the body after death should be 
elicited and respected.
7. Case examples
7.1 Case 1: a ‘simple’ case
Mrs. A is a 78 year-old woman with chronic obstructive lung disease with 
chronic hypoxic and hypercarbic respiratory failure, and pulmonary cachexia. 
Her baseline oxygen requirement is 3 liters of oxygen by nasal cannula around the 
clock. She has been in the intensive care unit (ICU) for three weeks with acute on 
chronic respiratory failure due to chronic obstructive pulmonary disease (COPD) 
exacerbation and pneumonia, which have been fully treated. She has failed non-
invasive ventilation repeatedly and was reintubated for the third time four days ago. 
She has spent a total of 16 days on the ventilator thus far. She has mild to moderate 
secretions and is able to expectorate them without distress. She is on assist control 
volume control with a tidal volume set at 6 mL/kg ideal body weight, requiring peak 
inspiratory pressure of 20, rate set at 12, PEEP of 5, and FiO2 35%.
She has a good cuff leak, but failed her spontaneous breathing trial this morning 
for dyspnea and tachypnea. She requests palliative extubation as she is not amenable 
to tracheostomy or prolonged ventilatory support.
She is awake, alert, able to write long coherent paragraphs about her under-
standing of the situation and about her wishes regarding her further care. Her 
spouse and children are understandably sad but supportive of her wishes, agree-
ing that this request is consistent with her long-stated wishes regarding prolonged 
life support. She is on no sedation and reports feeling comfortable on assist 
control.
After confirming the patient has capacity and is expressing a consistent choice 
with internally consistent logic based on good understanding of her medical 
condition, and answering any questions she or her legal surrogate or family have, 
the physician should discuss with the bedside nurse, RT, and when needed, the 
ICU charge nurse, to ensure the nurse and RT will have time to properly devote to 
this patient as the transition to comfort measures occurs. They should discuss what 
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as-needed medications she has been given over her ICU stay, and what her response 
has been to each, to determine what she is likely to need during the withdrawal 
process, and orders for these medications should be placed.
The physician or nurse should ask the patient and family if they wish to visit 
with a chaplain and when. If a chaplain visit is desired prior to transition to comfort 
measures, the chaplain should ensure they ask about any specific spiritual or cul-
tural practices they wish to observe. If the chaplain’s visit is declined, the physician 
and nurse should coordinate to explore culture or spiritual needs and wishes related 
to the transition process.
After the appropriate Do Not Resuscitate order is signed, and preparations for 
symptom management are made, and the patient and family are ready, as she is 
already on minimal ventilator settings, a spontaneous breathing trial should be 
initiated again, and comfort medications titrated to maintain her comfort with 
minimal ventilator support. Once she is comfortable on minimal ventilator sup-
port, she can be extubated when she and her family are ready, placed on oxygen via 
supplemental nasal cannula as is her baseline, and treated with the minimal effec-
tive dose of an opioid as needed for pain or dyspnea, or benzodiazepine as needed 
for primary anxiety, and supported until death or transition to another location for 
further care.
7.2 Case 2: a more challenging case
Mr. B is a 57 year-old with a remote mid-thoracic spinal cord injury with 
paraplegia but no known chronic respiratory insufficiency who was admitted to 
the intensive care unit 2 weeks ago for septic shock due to urinary tract infection 
with secondary bacteremia. He was initially intubated for respiratory fatigue after 
hours of working to compensate for lactic acidosis, but developed acute respiratory 
distress syndrome (ARDS) requiring PEEP of 18 cmH2O at most, FiO2 80–100%, 
with a set respiratory rate of 34. He has required pressors for the past two weeks, 
and developed renal failure requiring continuous renal replacement therapy for 
the past week. He requires deep sedation to maintain ventilator synchrony, and 
is encephalopathic and agitated when sedation is lightened. When updated at a 
meeting to discuss his clinical condition and values, preferences, and goals, his legal 
surrogate states he would not accept prolonged life support measures, including a 
tracheostomy, a longer-term feeding tube, or more than a few weeks of ventilator 
support or dialysis. The surrogate feels he has ‘had enough’ and would not want to 
continue current management; he feels the patient would wish to have Last Rites 
administered by a priest, and has no other specific requests for rituals surround-
ing death.
His code status is changed to Do Not Resuscitate. As soon as is feasible, family 
and friends are allowed a few hours to visit and say goodbyes. The patient’s priest 
comes to the hospital and administers Last Rites. The patient’s nurse and respiratory 
therapist are relieved of some of their other duties for a time, to be allowed to pro-
vide dedicated care to this patient. As discussed in the time out prior to withdrawal, 
first medications and therapies that do not improve his comfort are discontinued. 
Renal replacement therapy is then stopped and the machine is removed from the 
room. Vasopressors are then stopped. Blood pressure falls to a MAP of 50 mmHg 
but stabilizes, and heart rate increases from 90 to 110 and stabilizes.
His face appears calm and he is synchronous with the ventilator. His current 
opioid and benzodiazepine infusion rates are continued. Ventilator weaning is initi-
ated; rate is reduced by 4–6 breaths per minute, FiO2 is reduced by 10%, and PEEP 
by 2 cmH2O simultaneously. Tidal volume is not changed, or may be increased 
slightly to improve comfort. Any respiratory distress or apparent anxiety are treated 
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with boluses of opioids or benzodiazepines or both, and once controlled, rate, FiO2, 
and PEEP are weaned again with ongoing boluses and titration of bolus doses as 
warranted by his symptoms. His SpO2 falls to 60%, but his vital signs remain fairly 
unchanged. Once he is weaned to 30% with a PEEP of 6, and a set rate of 14 with 
a total rate of 18, and he appears comfortable based on lack of grimacing and lack 
of restlessness, the oroendotracheal tube is removed. Additional doses of opioids 
are given as needed for respiratory discomfort, and benzodiazepines are given as 
needed for evidence of anxiety. Family remains at the bedside until he dies.
7.3 Case 3: an unusual circumstance
Mr. C is a 30 year-old man with relapsed acute myeloblastic leukemia who devel-
ops severe tumor lysis syndrome after induction chemotherapy and is transferred 
to the ICU for management. He is started on a bicarbonate infusion and IV fluids. 
He is placed on BiPAP to support his respiratory compensation for acidemia while 
arrangements are made to start continuous renal replacement therapy, but is unable 
to maintain respiratory compensation for acidemia and is intubated. His respira-
tory rate is moderate, with minimal pressure and oxygen requirements. He remains 
remarkably alert, calm, and coherent after medications given for intubation wear 
off. After discussion of his overall condition, in which he has fully participated, 
he writes out clearly that he wants to transition to comfort care. The medical team 
discusses his physiologic derangements and recalls his extremely high respiratory 
rate prior to initiation of bicarbonate infusion. After a short spontaneous breathing 
trial in which he remains somewhat tachypneic but does not feel distressed.
He requests his code status be changed to Do Not Resuscitate and Do Not 
Intubate; these orders are completed. He is extubated to allow him to speak with his 
family. Continuous renal replacement therapy is continued for a few more hours 
until the cassette requires changing, at which time the set-up is taken down and not 
restarted. Bicarbonate infusion is continued to ameliorate his acidemia in hope of 
preventing dyspnea due to tachypnea. He is offered opioids for dyspnea when he 
appears to have respiratory distress and allowed to choose whether or not he feels 
he needs them, as well as being allowed to request them when needed. After several 
hours of good conversations with his family, he feels his breathing is tiring out and 
requests more frequent opioids, even if this means he may be too sleepy to interact 
with family. Opioids are given to relieve his dyspnea and respiratory distress. 
When the bicarbonate infusion bag is nearly empty, the rate is reduced and opioids 
are titrated to comfort before the bag is completed and the infusion stopped. His 
breathing pattern becomes irregula as he is no longer able to maintain compensa-
tion, and he appears comfortable until and through his death.
7.4 Case 4: a very challenging case
Mx. D is a 37 year-old person with antiphospholipid antibody syndrome and 
patent foramen ovale, with multiple deep venous thromboses and pulmonary 
emboli in the past, on therapeutic anticoagulation, develops diffuse alveolar hem-
orrhage and acute hypoxic respiratory failure requiring intubation and mechani-
cal ventilation. They are treated with steroids and inhaled tranexamic acid, and 
chronic anticoagulation is held. They unfortunately have several seizures and 
are found to have multiple embolic strokes with severe hemorrhagic conversion, 
including several of the cerebellum and visual cortex. On meeting with their fam-
ily including parents who are their legal surrogate, they feel that the likely long-
term impairments caused by the strokes would be unacceptable given their career 
as a dancer, and that they would not want to continue disease-directed therapies. 
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Given the continued moderate and occasionally large volume hemoptysis requiring 
suctioning through the oroendotracheal tube, the patient’s sibling, who is a respira-
tory therapist, expresses concern about the patient’s ability to breathe comfortably 
if extubated. Code status is changed to Do Not Resuscitate prior to transition to 
comfort care. Ventilator support is weaned down to the lowest PEEP level at which 
the patient appears comfortable. Pressure support, SIMV-PSV, and APRV with 
only a small difference between high and low PEEP. The medical team advises their 
family that the ventilator will continue to trigger after the patient’s death, as the 
ventilator’s apnea backup settings can be minimized but not completely discon-
tinued. Their comfort is maintained with opioid and benzodiazepines as needed 
until death.
7.5 Case 5: organ procurement
Ms. E is a 25 year-old woman with a long-standing history of opioid abuse 
including ingestion and injection- both subcutaneous and intravenous- of 
prescription opioid pills, and injection of heroin and fentanyl. She has suffered 
several overdoses requiring hospitalization and brief periods of intubation and 
mechanical ventilation in the past, has undergone rehab including some periods 
of abstinence, but has unfortunately suffered multiple relapses. Five days ago 
she was found unresponsive with agonal breathing at home after last speaking 
to family by phone hours earlier. MRI of the brain and serial head CT scans 
over several days in the ICU showed diffuse anoxic injury with severe edema 
and progressive herniation. Her clinical exam with normal electrolytes, normal 
temperature, and normal pCO2 and pH progresses to demonstrate no brainstem 
reflexes.
Several forms of testing clearly demonstrate brain death. The medical team 
informs and consoles her family, and requests the chaplain and social worker 
to further assist in supporting the family. The bedside nurse contacts the local 
organ procurement organization, whose representative comes to the hospital 
and reviews Ms. E’s case. She is noted to be a self-registered organ donor, and is 
deemed to be a candidate for donation of multiple organs. The representative 
from the organ procurement organization discusses with her family the process 
of assessing her and preparing for potential organ donation. She is maintained 
on mechanical ventilation via oroendotracheal tube. Pituitary failure is man-
aged with IV levothyroxine, DDAVP, and hydrocortisone. Blood pressure is 
maintained with vasopressors. When assessment is complete and the organ 
procurement organization and explant surgeons are available, she is taken to the 
operating room with a solemn procession in her honor, where life supports are 
withdrawn simultaneously. Cardiac death occurs 20 minutes later, and all viable 
organs are harvested for transplantation.
8. Conclusions
The above discussions, and the case examples, are not exhaustive of the situ-
ations clinicians may find themselves facing in the course of caring for patients. 
They are examples of some of the more common conditions that require consid-
eration and flexibility for patient-centered management. Far from a simple, ‘one 
size fits all’ process, they illustrate that palliative withdrawal of life supports is 
a medical procedure that requires thoughtful collaboration and consideration 
to provide each patient with the most comfortable transition to end of life care 
possible.
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